Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-042695
Filing Date
2025-03-20
Accepted
2025-03-20 16:23:21
Documents
79
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tern-20241231.htm   iXBRL 10-K 3508915
2 EX-4.3 tern-ex4_3.htm EX-4.3 45996
3 EX-10.9 tern-ex10_9.htm EX-10.9 38554
4 EX-19.1 tern-ex19_1.htm EX-19.1 102098
5 EX-23.1 tern-ex23_1.htm EX-23.1 6910
6 EX-31.1 tern-ex31_1.htm EX-31.1 17725
7 EX-31.2 tern-ex31_2.htm EX-31.2 17482
8 EX-32.1 tern-ex32_1.htm EX-32.1 9697
9 EX-32.2 tern-ex32_2.htm EX-32.2 9712
10 GRAPHIC img256829087_0.jpg GRAPHIC 246568
  Complete submission text file 0000950170-25-042695.txt   14172257

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tern-20241231.xsd EX-101.SCH 1735071
82 EXTRACTED XBRL INSTANCE DOCUMENT tern-20241231_htm.xml XML 2529680
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39926 | Film No.: 25756791
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)